SCHEMBL16094486

SCHEMBL16094486

C[C@@]12C(=CC(=O)C=C1OP(=O)(O)OP(=O)(O)O)CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 11/20 0.61
NR3C1 P04150 8/20 0.61
HSD17B10 Q99714 5/20 0.61
PGR P06401 5/20 0.61
CYP3A4 P08684 5/20 0.61
CYP2C19 P33261 3/20 0.61
SERPINA6 P08185 3/20 0.61
NR3C2 P08235 2/20 0.61
AR P10275 2/20 0.61
ABCB11 O95342 2/20 0.61
TNF P01375 1/20 0.61
IL6 P05231 1/20 0.61
GLUL P15104 1/20 0.61
ADAM17 P78536 1/20 0.61
GPBAR1 Q8TDU6 1/20 0.61
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
SHBG P04278 1/20 0.57
MAPT P10636 1/20 0.57
NFKB1 P19838 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7513 0.94 HIF1A (0.64) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL23828321 0.93 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL23565 0.93 HIF1A (0.63) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28303115 0.93 HIF1A (0.63) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28874596 0.92 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28388269 0.90 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL1930094 0.90 HIF1A (0.63) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL26126454 0.88 HIF1A (0.56) HIF1ANR3C1HSD17B10PGRCYP3A4
Phosphoric Acid SCHEMBL27656886 0.86 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL4751188 0.86 HIF1A (0.59) HIF1ANR3C1HSD17B10PGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2967984-A1 IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME Dose Medical Corporation (US) 2016-01-20 EP disclosed
WO-2014150292-A1 IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME DOSE MEDICAL CORPORATION (US) 2014-09-25 WO disclosed